☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Checkpoint Therapeutics
Checkpoint Therapeutics Reports New Results from Pivotal Studies of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma
July 28, 2023
Checkpoint Therapeutics Reports Interim Results of Cosibelimab in Registration-Enabling Trial for Locally Advanced Cutaneous Squam...
June 17, 2022
Checkpoint Reports Results of Cosibelimab in Registration-Enabling Trial for Metastatic Cutaneous Squamous Cell Carcinoma
January 27, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.